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Progress in both the fundamental and clinical phases of hematology during
recent years has been phenomenal. The complexity of bone marrow has been
greatly simplified, and the mystery, which for so many decades, surrounded the
spleen has become less enigmatic. Both spleen and marrow bear an intimate
relationship to each other, and, in turn, to the vital economy of the body as a
whole. In the detailed knowledge now available, we have the key to the solution
of a whole host of human diseases, some hitherto unrecognized, and, therefore,
uncontrolled. Moreover, some of the basic mechanisms are now revealed, whereby
new syndromes or combinations of disease syndromes may be detected early, and
direct rational measures of control instituted promptly with confidence and with
dramatic clinical results.
The most recent significant clinical application of basic information, accumu-
lated from a wide variety of sources through the past ten years of intensive chemical
and biological investigations, is that involving so-called folic acid, a derivative of
the vitamin B complex. There are five designations which have been somewhat
indiscriminately applied to this "group" of compounds: vitamin Be (essential to
growth and hemoglobinogenesis in young chicks), vitamin M (essential to hema-
topoiesis in monkeys), Lactobacillus casei factor (essential to the growth of these
milk-souring bacteria), folic acid (derived from the "foliage" of spinach), and
eluate factor (chemical procedure in processing liver, yeast and other natural
sources). A conjugate of Bc has been isolated from yeast, haying a more complex
molecular structure 2.8 times that of the simpler Bc obtained originally from
liver. Typical vitamin Bc may be obtained from the "conjugate" on enzyme
digestion.
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The culminating climax of these fascinating studies came last August (1945)
with the announcement by Angier and associates of the chemical synthesis of a
compound, recently revealed as pteroylglutamic acid, and ultraviolet and infra-
red absorption spectra, crystalline structure and biologic activity identical with
L. casei factor isolated in pure form from liver by Stoksted and Manning (1938).
The importance of this discovery cannot well be overemphasized or overstated.
The "yield" of this biologically essential molecule from natural sources, such as
liver, is exceedingly small, 0.1 ounce from one ton of beef liver, so that to have it
available in relatively unlimited quantities the synthetic chemist has immeasure-
ably enhanced its effective application both clinically and in further biologic
exploration.
Studies in this field were begun in this laboratory in 1940, with Drs. Woolpert,
Henry Wilson, Samuel Saslaw and associates in the Department of Medicine and
Bacteriology. Rhesus monkeys were used on experimental dietary regimes
and it was determined that without "folic acid-containing concentrates" a
gradual pan-marrow hypoplasia developed. Langston and associates had previ-
ously shown that diets of the Goldberger, black-tongue type were inadequate, and
that liver or yeast contained a common essential for normal hematopoiesis in the
monkey, "vitamin M." Granulocytopenia occurred in 100 per cent of our dietary
deficient monkeys, anemia in approximately 50 per cent. Folic acid concentrate
was found to be invariably effective in relieving the granulocytopenia at once,
within 24 hours, in our monkeys, and, in those animals showing also anemia, a
reticulocyte response was elicited followed by red cell and hemoglobin regeneration
entirely comparable to the anti-anemic response to liver extract. Blood thrombo-
cytes also returned to normal.
The translation and transferage of the animal results to clinical patients was
begun in the summer of 1943 in Birmingham, Alabama, in association with Dr.
Tom Spies. Patients chronically deficient in many dietary essentials, more par-
ticularly the vitamin B complex, were selected, who showed clinically, frequently
recurring oral ulcers, associated with a leucopenia hematologically. Folic acid
was then given under controlled conditions, and both clinical and hematologic
improvement was noted. Later the synthetic molecule was substituted for the
natural source with similar results.
With the availability of larger quantities of synthetic folic acid (pteroylglutamic
acid) in the early fall of 1945, Spies extended the use of this material to the
macrocytic anemias in and around Birmingham with spectacular responses.
Darby and Jones reported from Nashville the response of macrocytic anemia in
non-tropical spure, and Moore and associates in St. Louis and our own group
here, comprising Henry Wilson and Claude Starr Wright, found equally spectacular
results in Addisonian pernicious anemia and the macrocytic anemia of pregnancy.
Spies then showed that the macrocytic anemia of tropical sprue in Cuba responds
promptly. Furthermore, it has been established that those patients sensitive to
liver and liver extract may receive folic acid synthetic with impunity and with
the maintenance of complete clinical and hematologic remissions. It remains to
be proved whether the neurological changes, associated with pernicious anemia
in many patients, will remain permanently under control with folic acid.
There is good reason to believe at the present time that pteroylglutamic acid
is not the active principle in liver nor is it the extrinsic factor of Castle. The exact
and precise role of this extremely interesting and important molecule in the complex
chemistry of hematopoiesis remains to be determined, but a new and fascinating
chapter is being written in fundamental biological mechanisms and a new and
potent therapeutic agent has been made available for the relief of a large number of
human sufferers.
